| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/26/2008 | EP1902058A2 A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof |
| 03/26/2008 | EP1902025A1 Kinase inhibitors |
| 03/26/2008 | EP1740592A4 Methyl 2,4,9-trithiaadamantane-7-carboxylate |
| 03/26/2008 | EP1725567B1 Spirocyclic cyclohexane derivatives with affinity to the orl-1 receptor |
| 03/26/2008 | CN101151268A Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, preparation method, compositions containing same and use |
| 03/26/2008 | CN101151267A Chemical compounds |
| 03/26/2008 | CN101151031A Tricyclic cytoprotective compounds |
| 03/26/2008 | CN100376581C [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents |
| 03/26/2008 | CN100376572C Anti-infective agents |
| 03/26/2008 | CN100376569C Inhibitors of farnesyl protein transferase |
| 03/25/2008 | US7348441 Methyl 2,4,9-trithiaadamantane-7-carboxylate |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | CA2268709C Hiv protease inhibitors |
| 03/20/2008 | WO2008032995A1 Clopidogrel(+)-camphorsulfonate salt, method of preparing the same and a pharmaceutical composition comprising the same |
| 03/20/2008 | WO2008031888A2 Condensed pyrimidinones active on glutamatergic receptors |
| 03/20/2008 | WO2008008907A3 Antiviral agents |
| 03/20/2008 | WO2007084391A3 Thiazole compounds as protein kinase b ( pkb) inhibitors |
| 03/20/2008 | US20080071097 electrooptic display; liquid crystals |
| 03/20/2008 | US20080070913 Thieno [ 3,2-b] pyridine-6-carbonitriles and thieno [2,3-b] pyridine-5-carbonitriles as protein kinase inhibitors |
| 03/20/2008 | US20080070896 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example |
| 03/20/2008 | US20080069817 Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
| 03/19/2008 | EP1899355A1 Thienopyrimidine and thienopyridine derivatives as flt-3 kinase inhibitors |
| 03/19/2008 | EP1899354A1 Synthesis of deoxybiotinyl hexamethylenediamine-dota |
| 03/19/2008 | EP1899353A1 Thienopyrimidines for pharmaceutical compositions |
| 03/19/2008 | EP1530573B1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 03/19/2008 | EP1490344B1 Anxiolytic agents with reduced sedative and ataxic side effects |
| 03/19/2008 | EP1432715B1 Pyrimidine derivatives |
| 03/19/2008 | CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/18/2008 | US7345046 Using quinazoline type compound ; antiproliferative agents |
| 03/18/2008 | CA2315927C Oral pharmaceutical pulsed release dosage form |
| 03/13/2008 | WO2008008024A9 Polymorphic forms of spirapril hydrochloride |
| 03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 03/13/2008 | WO2007052167A3 Stable composition for a pharmaceutical formulation containing olanzapine |
| 03/13/2008 | WO2006078731A3 Amorphous and crystalline forms of dorzolamide hydrochloride and processes of making same |
| 03/13/2008 | US20080064874 2-Halofuryl/Thienyl-3-Carboxamides |
| 03/13/2008 | US20080064718 Inhibitors of protein tyrosine kinase activity |
| 03/13/2008 | US20080064691 Heterocyclic Amide Derivatives Which Possess Glycogen Phosphorylase Inhibitory Activity |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1896484A2 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 03/12/2008 | EP1896483A2 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 03/12/2008 | EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 03/12/2008 | EP1456657A4 Tagged microparticle compositions and methods |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/12/2008 | CN100374444C Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 03/12/2008 | CN100374435C Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 03/06/2008 | WO2008028094A1 Compounds as cb2 cannabinoid receptor ligands |
| 03/06/2008 | WO2008028093A1 Compounds as cb2 cannabinoid receptor ligands |
| 03/06/2008 | WO2008026602A1 Heteroacene derivative, tetrahaloterphenyl derivative, and their production methods |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | US20080058333 Carbamates such as (1-benzylcyclohexyl)methyl(1S)-5-[(4-morpholinylcarbonyl)amino]-1-(oxo([(1R)-1-phenylethyl]amino)acetyl)pentylcarbamate; osteoporosis |
| 03/06/2008 | US20080058308 2-carbonylamino-4,6-dihydrothieno[2,3-c]furans such as ethyl 2-{[2-fluoro-6-(trifluoromethyl)benzoyl]amino}-4-methyl-4,6-dihydrothieno[2,3-c]furan-3-carboxylate; CB2 receptors ligands for immune and inflammatory conditions; pain; neuroprotectants |
| 03/06/2008 | US20080058307 Novel compounds as cannabinoid receptor ligands |
| 03/05/2008 | EP1893618A2 Tetrahydropyridothiophenes for use in the treatment of cancer |
| 03/05/2008 | EP1893566A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/04/2008 | US7339045 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, lipids, cells, virus particles, fatty acids, polysaccharides) |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 03/04/2008 | US7338805 Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules |
| 02/28/2008 | WO2008024724A1 Aza-benzothiophenyl compounds and methods of use |
| 02/28/2008 | WO2008023828A1 Chromene compound |
| 02/28/2008 | WO2008022725A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral disorders |
| 02/28/2008 | WO2008022467A1 2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof |
| 02/28/2008 | US20080051581 Novel process for the manufacture of (+)-(S)-clopidogrel bisulfate form-1 |
| 02/28/2008 | US20080051446 Heterocyclocarboxamide Derivatives |
| 02/28/2008 | US20080051405 Therapeutic Agents |
| 02/28/2008 | US20080051386 Tricyclic Pyrazole Derivatives as Cannabinoid Receptor Modulators |
| 02/28/2008 | US20080051384 Antiviral agents |
| 02/28/2008 | CA2660963A1 Aza-benzothiophenyl compounds and methods of use |
| 02/28/2008 | CA2660957A1 2-phenoxy pyrimidinone analogues |
| 02/28/2008 | CA2660951A1 Haloalkyl-substituted pyrimidinone derivatives |
| 02/28/2008 | CA2660084A1 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 02/27/2008 | EP1891021A1 Aspartyl protease inhibitors |
| 02/27/2008 | EP1891000A1 Sphingolipids |
| 02/27/2008 | EP1737868B1 Stereoselective method for the production of clopidogrel |
| 02/27/2008 | EP1716155B1 Substituted thieno- and thiazolo[2,3-d]pyrimidines and [2,3-c]pyridines as inhibitors of tie2 |
| 02/27/2008 | CN101133063A Thienopyridine derivatives and use thereof as hsp90 modulators |
| 02/27/2008 | CN100370989C Use of 5-HT5-ligands in treatment of neurodegenerative and neuropsychiatric disturbances |
| 02/26/2008 | US7335778 Intermediate for biotin and process for producing the same |
| 02/26/2008 | US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/21/2008 | WO2008020799A1 Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020206A2 Fused thiophene derivatives as mek inhibitors |
| 02/21/2008 | WO2008020024A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer |
| 02/21/2008 | WO2007149451A3 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 02/21/2008 | WO2007146759A3 Novel mch receptor antagonists |
| 02/21/2008 | US20080045529 Use Of Thienopyrimidines |
| 02/21/2008 | US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer |
| 02/21/2008 | US20080045498 Polycyclic viral inhibitors |
| 02/21/2008 | CA2660794A1 Ntetrahydropyridothiophene derivatives for the treatment of cancer |
| 02/20/2008 | EP1888593A2 Thienopyridines |
| 02/20/2008 | EP1888592A1 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 02/20/2008 | EP1888585A1 Tetracyclic azapyrazinoindolines as 5-ht2 ligands |
| 02/20/2008 | CN101128470A New compounds |
| 02/20/2008 | CN101128450A New thiophene compound and method for producing kahweofuran or its analog using the same as raw material |
| 02/20/2008 | CN100369917C Himbacine analogues as thrombin receptor antagonists |
| 02/20/2008 | CN100369872C Method for hydrogenating C-C double bonds |
| 02/19/2008 | US7332519 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 02/19/2008 | US7332513 N-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-formamide for example; compound forms a naturally occurring metabolite when NO is released to slow or prevent drug tolerance; treating cardiovascular diseases, inflammation, psychiatric and neurological diseases, respiratory diseases, urogenital disorders |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |